- Home
- NXDT vs ALEC Comparison
NXDT vs ALEC Comparison
Compare NXDT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NXDT | ALEC |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.1M | 204.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NXDT | ALEC |
|---|---|---|
| Price | $4.75 | $1.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 133.6K | ★ 868.8K |
| Earning Date | 01-01-0001 | 02-26-2026 |
| Dividend Yield | ★ 9.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.99 | N/A |
| Revenue | N/A | ★ $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.41 | ★ N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $5.89 | $0.87 |
| 52 Week High | $13.07 | $3.40 |
Technical Indicators
Market Signals| Indicator | NXDT | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 56.94 | 52.02 |
| Support Level | $4.72 | $1.86 |
| Resistance Level | $5.14 | $2.00 |
| Average True Range (ATR) | 0.28 | 0.12 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 39.06 | 40.98 |
Price Performance
Historical ComparisonAbout NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.